BIOSTAR PHARMACEUTICALS, INC. BSPM Balance Sheet

Biostar pharmaceuticals, inc. (BSPM)

Balance Sheet / TTM

Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
ASSETS
Current Assets
Cash and cash equivalents
364	407	483	173	659	207	91	38	111	313	2,709	1,685	7,799	9,341	7,132	80	10,551	9,951	6,457	1,759	12,119	18,709	21,970	16,971	24,006	20,378	13,211
Notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	0	9,747	10,049	1,636	10,850	10,475	10,012	9,510	-	-	-	0	-	-	-
Note receivable - note 2)
-	-	-	-	-	-	-	-	-	-	-	-	-	0	1,622	-	-	-	-	0	-	-	-	-	-	-	-
Accounts receivable, net
0	0	5,555	6,741	6,094	7,751	14,712	15,814	29,190	28,931	24,617	26,962	29,366	24,665	18,992	17,965	13,076	13,478	16,507	21,851	28,815	23,581	34,469	35,033	32,465	32,589	28,535
Inventories
170	167	164	166	439	317	293	234	632	517	395	673	739	669	732	830	1,214	1,744	1,414	847	985	845	951	1,373	1,812	1,669	351
Tax prepaid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	451	452	-	-	-	-	-
Deposits and other receivables
335	192	17	171	2	2	2	2	2,009	2,978	3,699	4,471	719	1,391	3,164	5,282	7,622	5,635	7,751	7,740	5,390	6,612	7,160	7,129	1,309	1,296	1,251
Loan receivables, net
-	-	-	-	0	0	0	-	9,443	9,854	9,821	9,772	10,041	-	-	9,816	-	-	-	-	-	-	-	-	-	-	-
Value-added tax recoverable
51	50	48	41	22	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax recoverable
74	72	72	71	74	74	135	76	120	67	67	67	501	464	30	374	157	161	288	265	-	-	-	0	-	-	-
Prepaid research and development expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	789	1,582	2,371	-	-	-	-
Total Current Assets
996	891	6,342	7,365	7,292	8,352	15,235	16,167	41,508	42,663	41,311	43,633	49,168	46,279	41,725	35,985	43,473	41,446	42,431	41,974	48,551	51,783	66,924	60,508	59,594	55,934	43,350
Non-current Assets
Deposits
26,579	26,070	21,312	21,148	15,672	15,730	16,206	16,099	10,072	10,511	10,476	8,795	3,900	3,899	3,894	3,926	0	-	8,766	8,718	0	-	-	3,148	10,174	6,962	7,713
Deferred tax assets, net
2,625	2,574	2,534	2,515	5,262	5,282	5,442	5,406	7,390	7,775	7,581	7,065	3,225	3,509	2,902	2,789	3,224	3,508	3,325	3,665	3,328	3,441	1,108	1,617	-	-	-
Property and equipment, net
5,845	5,819	5,817	5,866	6,270	6,406	6,749	6,810	7,769	8,310	8,426	8,483	7,757	7,877	7,527	7,728	7,822	7,876	6,912	6,980	7,038	7,158	7,262	7,379	5,899	5,960	5,958
Intangible assets, net
5,380	5,420	5,485	5,607	6,061	6,284	6,740	6,878	11,726	12,690	12,994	13,270	14,927	15,672	16,378	17,134	17,857	18,354	8,857	9,136	9,390	9,729	10,067	10,406	10,832	10,910	11,064
Total Non-Current Assets
40,430	39,886	35,150	35,137	33,266	33,703	35,139	35,196	36,959	39,287	39,479	37,614	78,980	77,237	72,428	31,578	72,378	71,186	70,292	70,475	68,309	72,113	85,363	83,061	86,501	79,768	68,086
Total Assets
41,427	40,777	41,492	42,502	40,559	42,056	50,375	51,363	78,467	81,950	80,790	81,247	-	-	-	67,564	-	-	-	-	-	-	-	-	-	-	-
LIABILITIES AND STOCKHOLDERS EQUITY
Current Liabilities
Due to a related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	107	-	0	0	0	1,585	-	-	-	0	-	334	-
Short-term bank loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	790	-	782	773	-
Accounts and other payables
2,686	2,731	2,528	2,842	0	4	40	112	48	594	190	432	0	540	445	344	-	-	-	629	451	147	831	895	851	1,078	1,509
Accounts and other payables
-	-	-	-	4,097	3,840	3,844	4,153	7,502	5,778	4,703	5,001	5,665	5,489	5,367	4,447	5,236	5,542	6,271	5,732	3,644	2,403	4,288	3,334	6,129	5,722	3,991
Short-term bank loans
2,427	2,380	2,343	2,325	2,422	2,431	2,504	2,773	2,809	2,931	2,946	3,094	3,250	3,249	-	0	4,882	4,853	4,781	4,755	-	-	-	787	-	-	-
Warrants liability
166	179	438	455	12	14	31	59	158	302	393	383	619	567	960	0	-	-	-	-	-	-	-	-	-	-	-
Value-added tax payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	518	438	462	-	92	106	584	1,643	3,521	1,895	2,086
Total Current Liabilities
5,279	5,290	5,310	5,623	6,532	6,291	6,421	7,098	10,518	9,607	8,234	8,911	8,916	9,279	6,881	4,791	10,638	10,835	11,515	12,702	4,187	2,657	6,495	6,660	11,285	9,805	7,586
Total Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	9,535	9,847	-	-	-	-	-	-	-	-	-	-	-	-	-
Commitment and contingencies
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Common stock, $0.001 par value, 100,000,000 shares authorized, 2,637,188 shares issued and outstanding as of September 30, 2017 and December 31, 2016
2	2	2	2	2	2	2	2	15	15	15	2	15	14	14	12	12	11	9	9	9	9	9	9	28	27	27
Additional paid-in capital
31,382	31,382	31,382	31,382	30,316	30,316	30,316	30,316	30,303	30,303	30,303	30,316	30,303	28,648	28,648	25,748	25,240	24,633	23,272	23,266	23,238	22,517	22,488	22,445	22,348	22,199	20,706
Deferred stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	66	165	265	365	-	-	-	0	-	-	-	-	-	-	-
Statutory reserve
7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,354	7,126	7,126	7,126	7,126	6,737	6,737	6,737	6,737	6,490	6,490	6,490	6,490	4,666	4,666	4,666
Accumulated deficit
-4,994	-4,869	-3,555	-2,540	-5,929	-4,365	2,537	3,157	26,362	27,617	28,109	28,269	25,841	25,601	23,956	23,649	23,446	23,059	23,790	23,229	30,219	36,158	45,641	43,473	44,464	40,000	33,124
Accumulated other comprehensive income
2,403	1,616	997	680	2,282	2,456	3,743	3,434	3,912	7,052	6,773	6,391	6,224	6,165	6,066	6,600	6,303	5,908	4,966	4,528	4,163	4,280	4,237	3,982	3,708	3,068	1,975
Total Stockholders Equity
36,147	35,486	36,181	36,879	34,026	35,764	43,954	44,265	67,948	72,343	72,556	72,335	69,444	67,390	65,546	62,772	61,739	60,351	58,777	57,772	64,121	69,456	78,867	76,401	75,215	69,962	60,499
Total Liabilities and Stockholders Equity
41,427	40,777	41,492	42,502	40,559	42,056	50,375	51,363	78,467	81,950	80,790	81,247	78,980	77,237	72,428	67,564	72,378	71,186	70,292	70,475	68,309	72,113	85,363	83,061	86,501	79,768	68,086